Skip to content
PoliticalRepoPoliticalRepo

Person

Official portrait of Rep. Joyce, John [R-PA-13]

Rep. Joyce, John [R-PA-13]

United States · Official source

Records

891 records where Rep. Joyce, John [R-PA-13] is listed as a sponsor, author, or other actor. Search with topics and years

Bill· HRH.R. 10645 (119th)referred

SMART Act

United States · United States Congress · 1 October 2026

Bill· HRH.R. 9970 (119th)referred

RESCUE Act of 2026

United States · United States Congress · 27 July 2026

Bill· HJRESH.J.Res. 205 (119th)referred

Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "California State Motor Vehicle Pollution Control Standards; Notice of Decision Granting a Waiver of Clean Air Act Preemption for California's Advanced Clean Car Program and a Within the Scope Confirmation for California's Zero Emission Vehicle Amendments for 2017 and Earlier Model Years".

United States · United States Congress · 23 July 2026

Bill· HRH.R. 9829 (119th)referred

ORTHO Act

United States · United States Congress · 22 July 2026

Bill· HRH.R. 9599 (119th)referred

SECURE 340B Act

United States · United States Congress · 6 July 2026

Bill· HRH.R. 9418 (119th)referred

Access to Innovative Treatments Act of 2026

United States · United States Congress · 24 June 2026

Access to Innovative Treatments Act of 2026 This bill requires the Centers for Medicare & Medicaid Services (CMS) to review adverse national coverage determinations of drugs under Medicare within 30 days of receiving a request to do so. Specifically, the CMS must review within 30 days any denials or limitations of coverage that are inconsistent with the drug's approval by the Food and Drug Administration (FDA). The bill's requirements do not apply if the CMS already conducted such a review within a two-year period. The bill also prohibits the CMS from applying prior coverage determinations that were made for drugs before they were approved by the FDA if such determinations are inconsistent with the drug's approval.

Bill· HRH.R. 9002 (119th)referred

SURS Extension Act

United States · United States Congress · 21 May 2026

Small Practice, Underserved, and Rural Support Program Extension Act of 2023 or the SURS Extension Act This bill reauthorizes funds through FY2031 for the Centers for Medicare & Medicaid Services to contract with specified entities (e.g., quality improvement organizations) to provide technical assistance regarding the Merit-based Incentive Payment System (MIPS) and alternative payment models under Medicare, specifically for health professionals in practices with 15 or fewer professionals. (MIPS is an incentive program under Medicare that allows health professionals to receive payment adjustments based on certain performance measures.)

Bill· HRH.R. 8413 (119th)referred

SECURE Data Act

United States · United States Congress · 21 April 2026

Bill· HRH.R. 8425 (119th)referred

Strengthening the Vaccines for Children Program Act of 2026

United States · United States Congress · 21 April 2026

Strengthening the Vaccines for Children Program Act of 2026 This bill expands vaccination programs and coverage for children under Medicaid and the Children's Health Insurance Program (CHIP). Specifically, the bill expands and otherwise modifies the Vaccines for Children Program, which provides free vaccinations to individuals 18 years of age or younger who are uninsured or underinsured (i.e., with limited or no insurance for vaccines), are eligible for Medicaid, or are American Indians or Alaskan Natives. The bill expands the program to include children enrolled in CHIP. The Government Accountability Office must report on the related effects of the bill's changes. The bill also temporarily requires payments under Medicaid and CHIP for vaccine administration and counseling services for children to be made at a rate that is no less than the rate under Medicare for equivalent services. It also increases the Federal Medical Assistance Percentage (i.e., federal matching rate) for states that conduct culturally appropriate outreach regarding the benefits of vaccinations for children.

Bill· HRH.R. 8414 (119th)referred

DAIRY PRIDE Act

United States · United States Congress · 21 April 2026

Bill· HRH.R. 8300 (119th)referred

Swalwell Act

United States · United States Congress · 15 April 2026

Bill· HRH.R. 8163 (119th)reported

Provider Reimbursement Stability Act of 2026

United States · United States Congress · 30 March 2026

Provider Reimbursement Stability Act of 2026 This bill allows for larger annual adjustments to the Medicare physician fee schedule. It also requires the Centers for Medicare & Medicaid Services (CMS) to make certain corrections to compensate for expenditures under the fee schedule that exceed a certain amount in a given year, and it limits how much certain adjustment factors may vary each year. Current law prohibits annual adjustments to the Medicare physician fee schedule that would result in a more than $20 million difference between the adjusted amount and the non-adjusted amount of total expenditures. The bill increases this threshold to $54.3 million beginning in 2027, with adjustments for inflation every five years beginning in 2032. Additionally, for certain services, the bill requires the CMS to determine the difference between expenditures based on estimated utilization of the service and expenditures based on actual utilization. If this difference exceeds a certain percentage of total expenditures under the fee schedule, the CMS must reconcile this difference by adjusting payments for the following year. This requirement applies to services for which payment was bundled with another service and there was a separate or add-on payment during the previous year. Finally, the CMS must update the prices and rates of each category of direct costs that affect payments (e.g., prices of equipment) at least every five years, with updates made to each category in the same year. The bill also prohibits the CMS from varying a certain adjustment factor by more than 2.5% each year.

Bill· HRH.R. 8076 (119th)referred

PREDICT Act

United States · United States Congress · 25 March 2026

Bill· HRH.R. 7871 (119th)referred

MVP Act

United States · United States Congress · 9 March 2026

Medicaid VBPs for Patients Act or the MVP Act This bill provides statutory authority for regulations that allow for the use of varying best price points under value-based purchasing arrangements for purposes of the Medicaid Drug Rebate Program. ( Value-based purchasing arrangements refer to arrangements in which the price of a drug is linked to clinical outcomes; such arrangements are particularly used for new high-cost treatments, such as gene therapies.) The Government Accountability Office must study the impact of value-based purchasing arrangements on federal health care programs, including with respect to the bill's changes. Additionally, the bill (1) exempts sales of drugs that are made under value-based purchasing arrangements from calculations of the manufacturer average sales price for purposes of payments under Medicare medical services, if the manufacturer reports multiple best prices under Medicaid in accordance with the bill's changes; and (2) requires the Centers for Medicare & Medicaid Services to issue guidance on how state Medicaid programs may cover drugs in inpatient settings via value-based purchasing arrangements.

Resolution· HRESH.Res. 1022 (119th)referred

Supporting the contributions of Catholic schools in the United States and celebrating the 52nd annual National Catholic Schools Week.

United States · United States Congress · 27 January 2026

This resolution supports the goals of National Catholic Schools Week, an event cosponsored by the National Catholic Educational Association and the U.S. Conference of Catholic Bishops and established to recognize the contributions of Catholic elementary and secondary schools in the United States.

Bill· HRH.R. 7008 (119th)open

Stop Insider Trading Act

United States · United States Congress · 12 January 2026

Stop Insider Trading Act This bill generally prohibits Members of Congress and their spouses and dependent children from purchasing stocks and requires public notice before these individuals may sell stocks. Specifically, Members of Congress and the spouses and dependent children of Members of Congress may not purchase covered investments. Between 7 and 14 days before a Member or a covered spouse or dependent sells a covered investment, the relevant Member must file public notice of the intent to sell with the Clerk of the House of Representatives or the Secretary of the Senate, as appropriate. The Clerk or Secretary must publish this notice online. If the individual decides not to sell the covered investment, the notice must be withdrawn. Under the bill, a covered investment is a security issued by a publicly traded company or a comparable economic interest. Some investments are exempt, including interest in a widely held investment fund and certain investments held in a trust. Violations of these provisions are subject to a fee and, in the case of a purchase, a requirement to sell the covered investment. The fee must equal (1) the greater of $2,000 or 10% of the transaction value, and (2) any net gain realized from the transaction during a specified period. The fee may not be paid using campaign donations or Members’ official allowances. Certain transactions by covered spouses and dependents are exempt, including transactions made on behalf of another person or made as part of compensation from the individual’s employer.

Bill· HRH.R. 6766 (119th)referred

Essential Caregivers Act of 2025

United States · United States Congress · 16 December 2025

Essential Caregivers Act of 2025   This bill prohibits certain health care facilities from limiting the access of essential caregivers to residents of those facilities, including during designated emergency periods.   Specifically, the bill generally prohibits Medicare skilled nursing facilities, Medicaid nursing facilities, Medicaid intermediate care facilities, and associated inpatient rehabilitation facilities from restricting the access of essential caregivers to residents of the facilities, including during emergency periods in which visitation rights are otherwise restricted. During emergency periods, facilities may restrict access for an initial period of up to seven days and for one additional maximum seven-day period (if the additional period is approved by the state health department). Facilities may restrict access for a total of 7 days (or 14 days with the approval of the state health department) during an emergency period. Essential caregivers must agree to comply with any safety protocols set by the facility, which may be no more stringent for caregivers compared to those for staff. Caregivers who fail to comply with these requirements may be denied access, subject to an appeals process.

Bill· HRH.R. 6398 (119th)referred

RED Tape Act

United States · United States Congress · 3 December 2025

Reducing and Eliminating Duplicative Environmental Regulations Act or the RED Tape Act This bill removes the requirement under the Clean Air Act that the Environmental Protection Agency (EPA) review and comment on newly authorized federal construction projects and other major federal agency actions that already require review under the National Environmental Policy Act (NEPA) and proposed federal regulations.

Bill· HRH.R. 6130 (119th)referred

ASAP Act

United States · United States Congress · 19 November 2025

Bill· HRH.R. 6046 (119th)reported

Broadband and Telecommunications RAIL Act

United States · United States Congress · 17 November 2025

Broadband and Telecommunications RAIL Act This bill establishes a framework for the placement or modification of broadband or telecommunications equipment in a railroad corridor. Specifically, if a broadband or telecommunications provider is seeking to place or modify equipment within a railroad carrier’s right-of-way, the provider must submit an application to the carrier. A carrier must approve or deny an application within 60 days of receipt, and may only deny an application for safety reasons or if the placement or modification would substantially interfere with or damage railroad infrastructure. Once an application is approved, work must be scheduled in coordination with the carrier and generally must begin within 30 days. A provider must pay the railroad carrier for actual costs incurred with respect to the application. However, if a provider has been authorized by a state or local government to place or modify equipment in a public right-of-way in an area that intersects with a railroad corridor, the provider need only notify the relevant railroad carrier and schedule the work in coordination with the carrier. Work must generally begin between 15 and 30 days after the notification is submitted. No fee is required. A provider or carrier may petition the Federal Communications Commission (FCC) for relief if the other has failed to comply with these provisions. The FCC must promulgate regulations to implement these provisions in a manner that ensures railroad safety, provides a timelier process for emergency situations, and prevents substantial interference with railroad infrastructure or operations, among other requirements.

Bill· HRH.R. 6019 (119th)open

To repeal certain provisions relating to notification to Senate offices regarding legal process on disclosure of Senate data, and for other purposes.

United States · United States Congress · 12 November 2025

This bill repeals the authority for a Senator to bring a civil action against the federal government if an internet service provider or the Senate Sergeant at Arms (SAA) accessed or disclosed, or accesses or discloses, data from the Senator's office to provide to a federal agency without following prescribed notice requirements. The authority applies to a qualifying instance occurring on or after January 1, 2022.  The authority for the civil action was enacted in H.R. 5371, the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 , which was signed by the President on November 12, 2026. The relevant provision requires written notice from the internet service provider or the SAA to the Senate office upon receipt of any legal process seeking access or disclosure of covered data. A Senator affected by a federal violation of the provision may sue the federal government for the greater of $500,000 per violation or the actual damages, plus attorney's fees and related costs.

Bill· HRH.R. 5870 (119th)referred

Prevent Government Shutdowns Act

United States · United States Congress · 31 October 2025

Prevent Government Shutdowns Act This bill provides continuing appropriations to prevent a government shutdown if the appropriations bills for a fiscal year have not been enacted before the fiscal year begins and continuing appropriations are not in effect. Specifically, the bill provides appropriations at the rate of operations that was provided for the prior fiscal year to continue programs, projects, and activities that were funded in the preceding fiscal year. The bill also limits official travel, congressional recesses or adjournments, and the consideration of legislation that is unrelated to appropriations after the beginning of a fiscal year if the appropriations process has not been completed.